Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy Improves the Accuracy of Sentinel Lymph Node Biopsy in Melanoma

Background: Despite advances in melanoma management, there remains room for improvement in the accuracy of sentinel lymph node biopsy. The authors analyzed a prospective cohort of patients with primary cutaneous melanoma who underwent sentinel lymph node biopsy with lymphoscintigraphy and indocyanine green fluorescence to evaluate the quality and accuracy of this technique. Methods: Consecutive primary cutaneous melanoma patients who underwent sentinel lymph node biopsy with radioisotope lymphoscintigraphy and indocyanine green fluorescence from 2012 to 2018 were prospectively enrolled. Analysis was performed of melanoma characteristics, means of identifying sentinel lymph nodes, sentinel lymph node status, and recurrence. Results: Five hundred ninety-four melanomas and 1827 nodes were analyzed; 1556 nodes (85.2 percent) were identified by radioactivity/fluorescence, 255 (14 percent) by radioactivity only, and 16 (0.9 percent) with indocyanine green only. There were 163 positive sentinel nodes. One hundred forty-seven (90.2 percent) were identified by radioactivity/fluorescence, 13 (8 percent) by radioactivity only, and three (0.6 percent) with fluorescence only. Of the 128 patients with a positive biopsy, eight patients’ (6.3 percent) nodes were identified by radioactivity only and four (3.4 percent) with fluorescence only. There were 128 patients with a positive biopsy, 454 with a negative biopsy, and 12 patients who had a negative biopsy with subsequent nodal recurrence. Mean follow-up was 2.8 years. Conclusions: In the study of the largest cohort of patients with primary cutaneous melanoma who underwent a sentinel lymph node biopsy with radioisotope lymphoscintigraphy and indocyanine green–based technology, the quality and accuracy of this technique are demonstrated. This has important implications for melanoma patients, as the adoption of this approach with subsequent accurate staging, adjuvant workup, and treatment may improve survival outcomes.  CLINICAL QUESTION/LEVEL OF EVIDENCE: Diagnostic, II.

[1]  C. Cakmakoglu,et al.  Lymphaticovenous Bypass for Immediate Lymphatic Reconstruction in Locoregional Advanced Melanoma Patients , 2019, Journal of Reconstructive Microsurgery.

[2]  C. Cakmakoglu,et al.  Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate , 2019, Annals of Surgical Oncology.

[3]  S. Mocellin,et al.  Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases. , 2019, European Journal of Surgical Oncology.

[4]  Michael E. Egger,et al.  Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System? , 2019, Journal of the American College of Surgeons.

[5]  I. Nunney,et al.  A feasibility study of indocyanine green fluorescence mapping for sentinel lymph node detection in cutaneous melanoma. , 2019, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[6]  A. Vahabzadeh‐Hagh,et al.  Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system. , 2018, American journal of otolaryngology.

[7]  R. Neves,et al.  Indocyanine green and fluorescence lymphangiography for sentinel node identification in patients with melanoma. , 2018, American journal of surgery.

[8]  B. Gastman,et al.  Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma. , 2018, The Journal of surgical research.

[9]  D. Schadendorf,et al.  Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma , 2018, The New England journal of medicine.

[10]  B. Gastman,et al.  Determining the False-Negative Rate Using Fluorescence Image–Assisted Sentinel Lymph Node Biopsy in Cutaneous Melanoma , 2017, Annals of plastic surgery.

[11]  R. Braun,et al.  Update on adjuvant melanoma therapy , 2017, Current opinion in oncology.

[12]  D. Elder,et al.  Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma , 2017, Journal of surgical oncology.

[13]  D. Narayan,et al.  Use of Indocyanine Green for Sentinel Lymph Node Biopsy: Case Series and Methods Comparison , 2017, Plastic and reconstructive surgery. Global open.

[14]  A. Hauschild,et al.  Adjuvant Dabrafenib plus Trametinib in Stage III BRAF‐Mutated Melanoma , 2017, The New England journal of medicine.

[15]  P. Ascierto,et al.  Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma , 2017, The New England journal of medicine.

[16]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[17]  H. Gollnick,et al.  Indocyanine green‐assisted sentinel lymph node biopsy in melanoma using the “FOVIS“ system , 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[18]  R. V. Valdés Olmos,et al.  The sentinel node approach in gynaecological malignancies , 2016, Clinical and Translational Imaging.

[19]  M. Faries,et al.  Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma , 2016, Annals of Surgical Oncology.

[20]  A. Tufaro,et al.  Current Trends and Emerging Future of Indocyanine Green Usage in Surgery and Oncology: An Update , 2015, Annals of Surgical Oncology.

[21]  M. Krimmel,et al.  Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival , 2015, Annals of Surgical Oncology.

[22]  E. Nacchiero,et al.  Sentinel lymph node biopsy in head and neck melanoma*. , 2014, Il Giornale di chirurgia.

[23]  T. Camerini,et al.  Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas. , 2014, The Journal of surgical research.

[24]  J. Korn,et al.  Indocyanine Green SPY Elite–Assisted Sentinel Lymph Node Biopsy in Cutaneous Melanoma , 2014, Plastic and reconstructive surgery.

[25]  M. Singer,et al.  Is Head and Neck Melanoma Different from Trunk and Extremity Melanomas with Respect to Sentinel Lymph Node Status and Clinical Outcome? , 2013, Annals of Surgical Oncology.

[26]  K. Delman,et al.  Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma , 2013, Head & neck.

[27]  J. Frangioni,et al.  Effective Low-dose Escalation of Indocyanine Green for Near-infrared Fluorescent Sentinel Lymph Node Mapping in Melanoma , 2013, Annals of Surgical Oncology.

[28]  Y. Fujisawa,et al.  Indocyanine green fluorescence‐navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false‐negative cases in skin cancer , 2012, Journal of surgical oncology.

[29]  M. Singer,et al.  Long-Term Prognosis and Significance of the Sentinel Lymph Node in Head and Neck Melanoma , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[30]  T. Saida,et al.  Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanoma , 2012, The Journal of dermatology.

[31]  K. Griffith,et al.  Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma , 2012, Cancer.

[32]  J. Klode,et al.  Indocyanine green fluorescence‐guided sentinel lymph node biopsy in dermato‐oncology , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[33]  A. Balm,et al.  Feasibility of Sentinel Node Biopsy in Head and Neck Melanoma Using a Hybrid Radioactive and Fluorescent Tracer , 2011, Annals of Surgical Oncology.

[34]  O. Nieweg,et al.  Less false‐negative sentinel node procedures in melanoma patients with experience and proper collaboration , 2011, Journal of surgical oncology.

[35]  A. Balm,et al.  Assessment of lymphatic drainage patterns and implications for the extent of neck dissection in head and neck melanoma patients , 2011, Journal of surgical oncology.

[36]  B. Pockaj,et al.  Can lymphatic drainage of head and neck melanoma be predicted? , 2011, Journal of surgical oncology.

[37]  M. Ross,et al.  Sentinel Lymph Node Biopsy in Cutaneous Melanoma , 2008 .

[38]  N. Yamazaki,et al.  Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma. , 2011, European journal of dermatology : EJD.

[39]  Matthew W. Miller,et al.  False-Negative Sentinel Lymph Node Biopsy in Head and Neck Melanoma , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[40]  G. Lyman,et al.  Sentinel Node Biopsy for Head and Neck Melanoma , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[41]  J. Shah,et al.  Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma , 2010, Head & neck.

[42]  Michael Hünerbein,et al.  ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer , 2010, Breast Cancer Research and Treatment.

[43]  I-Chih Tan,et al.  Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. , 2010, Open surgical oncology journal.

[44]  S. Ariyan,et al.  Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients , 2009, Annals of Surgical Oncology.

[45]  V. Sondak,et al.  Who Is to Blame for False-Negative Sentinel Node Biopsies in Melanoma? , 2009, Annals of Surgical Oncology.

[46]  K. Fogarty,et al.  A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck. , 2009, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[47]  Wataru Fujimoto,et al.  Sentinel lymph node detection in skin cancer using fluorescence navigation with indocyanine green , 2009, The Journal of dermatology.

[48]  L. Talve,et al.  Head and neck cutaneous melanoma: A retrospective observational study on 146 patients , 2009, Acta oncologica.

[49]  S. Mocellin,et al.  Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI) , 2009, Annals of Surgical Oncology.

[50]  J. Myers,et al.  Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: Recurrence and survival study , 2008, Head & neck.

[51]  Grant W. Carlson,et al.  Regional Recurrence After Negative Sentinel Lymph Node Biopsy for Melanoma , 2008, Annals of surgery.

[52]  E. Levine,et al.  Use of Sentinel Lymph Node Biopsy for Melanoma of the Head and Neck , 2007, The American surgeon.

[53]  G. Botti,et al.  Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous Melanoma , 2007, Annals of Surgical Oncology.

[54]  T. Teltzrow,et al.  Reliability of sentinel lymph-node extirpation as a diagnostic method for malignant melanoma of the head and neck region. , 2007, International journal of oral and maxillofacial surgery.

[55]  S. Muller,et al.  Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients , 2000, Annals of Surgical Oncology.

[56]  P. Rutkowski,et al.  Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous Melanoma , 2006, Annals of surgical oncology.

[57]  R. Elashoff,et al.  Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.

[58]  H. Hoekstra,et al.  Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? , 2006, Journal of surgical oncology.

[59]  M. Ross,et al.  Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. , 2006, Archives of otolaryngology--head & neck surgery.

[60]  M. Singer,et al.  Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy , 2006, Head & neck.

[61]  R. Uren.  Lymphatic drainage of the skin , 2004, Annals of Surgical Oncology.

[62]  D. McCready,et al.  Sentinel Lymph Node Biopsy for CutaneousMelanoma of the Head and Neck , 2005, Annals of Surgical Oncology.

[63]  R. Lyles,et al.  Sentinel Lymph Node Biopsy in the Management of Cutaneous Head and Neck Melanoma , 2005, Plastic and reconstructive surgery.

[64]  C. O'brien,et al.  Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy , 2004, Annals of Surgical Oncology.

[65]  H. Gutman,et al.  Sentinel node guided surgery for melanoma in the head and neck region , 2004, Melanoma research.

[66]  C. O'brien,et al.  Correlation Between Preoperative Lymphoscintigraphy and Metastatic Nodal Disease Sites in 362 Patients With Cutaneous Melanomas of the Head and Neck , 2004, Annals of surgery.

[67]  J. C. Alex,et al.  Candidate's Thesis: The Application of Sentinel Node Radiolocalization to Solid Tumors of the Head and Neck: A 10‐Year Experience , 2004, The Laryngoscope.

[68]  E. Even-Sapir,et al.  Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  H. Gietema,et al.  Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  M. Ross,et al.  Sentinel Lymph Node Biopsy for Head and Neck Melanomas , 2003, Annals of Surgical Oncology.

[71]  O. Nieweg,et al.  Review and Evaluation of Sentinel Node Procedures in 250 Melanoma Patients With a Median Follow-Up of 6 Years , 2003, Annals of Surgical Oncology.

[72]  Cecelia E Schmalbach,et al.  Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. , 2003, Archives of otolaryngology--head & neck surgery.

[73]  Ann M Gillenwater,et al.  A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. , 2002, Archives of otolaryngology--head & neck surgery.

[74]  J. Shah,et al.  Sentinel lymph node biopsy for cutaneous head and neck melanomas. , 2002, Archives of otolaryngology--head & neck surgery.

[75]  E. Prvulovich,et al.  Is there a role for lymphoscintigraphy and sentinel node biopsy in the management of the regional lymphatics in mucosal squamous cell carcinoma of the head and neck? , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  M. Heslin,et al.  Sentinel Node Biopsy for Cutaneous Melanoma in the Head and Neck , 2001, Annals of Surgical Oncology.

[77]  B. Rasgon.  Use of Low‐Dose Technetium Tc 99m Sulfur Colloid to Locate Sentinel Lymph Nodes in Melanoma of the Head and Neck: Preliminary Study , 2001, The Laryngoscope.

[78]  J. Vansant,et al.  Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. , 2000, Archives of otolaryngology--head & neck surgery.

[79]  J. Plukker,et al.  Sentinel node biopsy for melanoma in the head and neck region , 2000, Head & neck.

[80]  S. Leong,et al.  Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. , 1999, Archives of dermatology.

[81]  G. Lyman,et al.  Sentinel Lymph Node Biopsy in Melanoma of the Head and Neck , 1997, Plastic and reconstructive surgery.

[82]  C W Cruse,et al.  Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. , 1996, Annals of surgery.

[83]  C. O'brien,et al.  Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. , 1995, American journal of surgery.

[84]  C. Garbe,et al.  Primary cutaneous melanoma. Prognostic classification of anatomic location , 1995, Cancer.

[85]  D. Reintgen,et al.  The use of lymphoscintigraphy in melanoma of the head and neck. , 1994, Plastic and reconstructive surgery.

[86]  A. Cochran,et al.  Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  J. Shah,et al.  Patterns of regional lymph node metastases from cutaneous melanomas of the head and neck. , 1991, American journal of surgery.

[88]  R. Wahl,et al.  Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax. , 1987, Surgery.